Definition

A bispecific antibody that simultaneously binds two different as of yet undisclosed antigens, with potential immunomodulating and antineoplastic activities. Upon administration, dalutrafusp alfa targets and binds the two antigens. This may modulate the tumor microenvironment (TME) and may enhance an immune-mediated antitumor response.